MannKind Corporation (NASDAQ: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such a...
Grupo Supervielle Reacts to Difficult Argentine Economy, Analysts Review and Target
Grupo Supervielle S.A. (NYSE: SUPV) is a holding company with a long-standing presence in the Argentine financial system and a competitive leadership ...
CV Sciences Sales Are Booming, Debt Free and Potential Uplisting in the CBD Sector
CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel t...
Aurora Cannabis, Growing Like a Weed, New Financing and Analysts Opinion
Aurora Cannabis Inc. (OTCQX: ACBFF), through its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical c...
The9 Limited Continues Steps into the Blockchain Sector with Investments
The9 Limited (NASDAQ: NCTY), together with its subsidiaries, operates as an online game developer and operator in the People’s Republic of China...
BioSig Technologies Getting Traction with PURE EP ™ System, Could Move Following Listing on the NASDAQ
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company developing a proprietary biomedical signal processing technology designed to impro...
ATA Inc. Shares Soar on Sale of a Business Segment and Proposed Acquisition
ATA Inc. (NASDAQ: ATAI), through its subsidiaries, provides computer-based testing services in the People’s Republic of China. The company offer...
Rigel Pharmaceuticals, Traction from TAVALISSE Sales and Pipeline, Analysts Review and Target
Rigel Pharmaceuticals, Inc., (NASDAQ: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs t...
Marathon Patent Group Passes on Bitcoin Mining Merger, Developing its Own Bitcoin Mining Operation
Marathon Patent Group (NASDAQ: MARA) Passes on Merger and Decides to Develop its Own Bitcoin Mining Operation. Marathon Patent Group has as many as 20...
Affimed Shares Leap on News of Genentech Deal, Analysts Review and Target
Affimed N.V. (NASDAQ: AFMD) is a clinical-stage biopharmaceutical company, focused on cancer immunotherapies. Its lead candidate is AFM13, a natural k...